Hint mode is switched on Switch off

LABU - Direxion Daily S&P Biotech Bull 3X Shares (USD) (US25460G1206)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all

Leveraged

 
(%)
US25460G1206
LABU ISIN
Exchange Traded Funds (ETF)
Type of fund
Direxion Funds
Provider
177.2 USD
NAV per Share | 28/04/2026
28/05/2015
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
LABU
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
The S&P Biotechnology Select Industry Index
Benchmark
0.93 %
Total Cost Ratio
570.53 mln USD
Fund NAV | 28/04/2026
500.5 mln USD
Share Class NAV | 28/04/2026
No
UCITS
20 / 1 (02/12/2023)
Split

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 26/06/2026, NYSE Arca

  • YTD
    1.98 %
  • 1M
    -23.81 %
  • 3M
    -3.65 %
  • 6M
    17.4 %
  • 1Y
    219.99 %
  • 3Y
    27.39 %
  • 5Y
    -86.86 %
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Latest data on 28/04/2026
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (LABU)

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

LABU profile

The Direxion Daily S&P Biotech Bull 3X Shares (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Direxion Funds fund’s base currency is USD and the share class was registered 28.05.2015 with unique ISIN - US25460G1206. Main exchange is NYSE Arca and ticker symbol is LABU. The total expense ratio is 0.93%. The Direxion Daily S&P Biotech Bull 3X Shares (USD) pays dividends 4 time(s) per year.

Structure LABU on 29/06/2026

Download structure in Excel
Paper Value
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 69.52%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 51.02%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 47.55%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 43.31%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 29.15%
DREYFUS GOVT CASH MAN INS 27.55%
GOLDMAN FINL SQ TRSRY INST 506 17.72%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 11.11%
GOLDMAN SACHS FIN GOV 465 INSTITUT 4.26%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 3.94%
APOGEE THERAPEUTICS INC 0.67%
TWIST BIOSCIENCE CORP 0.62%
MODERNA INC 0.61%
ORUKA THERAPEUTICS INC 0.59%
KYMERA THERAPEUTICS INC 0.58%
VIKING THERAPEUTICS INC 0.57%
PRAXIS PRECISION MEDICINES I 0.57%
MIRUM PHARMACEUTICALS INC 0.55%
CG ONCOLOGY INC 0.55%
RHYTHM PHARMACEUTICALS INC 0.54%
REVOLUTION MEDICINES INC 0.53%
TRAVERE THERAPEUTICS INC 0.53%
ALKERMES PLC 0.53%
DIANTHUS THERAPEUTICS INC 0.52%
VAXCYTE INC 0.52%
SCHOLAR ROCK HOLDING CORP 0.52%
CYTOKINETICS INC 0.51%
COGENT BIOSCIENCES INC 0.51%
NATERA INC 0.51%
ROIVANT SCIENCES LTD 0.5%
TG THERAPEUTICS INC 0.5%
ERASCA INC 0.5%
KRYSTAL BIOTECH INC 0.5%
BEAM THERAPEUTICS INC 0.5%
RELAY THERAPEUTICS INC 0.49%
SPYRE THERAPEUTICS INC 0.49%
PROTAGONIST THERAPEUTICS INC 0.48%
PTC THERAPEUTICS INC 0.48%
UNIQURE NV 0.48%
ULTRAGENYX PHARMACEUTICAL IN 0.48%
CELCUITY INC 0.48%
VERA THERAPEUTICS INC 0.47%
VERTEX PHARMACEUTICALS INC 0.47%
ABBVIE INC 0.47%
INSMED INC 0.47%
ARROWHEAD PHARMACEUTICALS IN 0.47%
BIOGEN INC 0.47%
CRISPR THERAPEUTICS AG 0.47%
IONIS PHARMACEUTICALS INC 0.46%
IMMUNITYBIO INC 0.46%
MADRIGAL PHARMACEUTICALS INC 0.46%
INCYTE CORP 0.45%
SELLAS LIFE SCIENCES GROUP I 0.45%
HALOZYME THERAPEUTICS INC 0.45%
AMGEN INC 0.44%
GILEAD SCIENCES INC 0.44%
REGENERON PHARMACEUTICALS 0.44%
BIOMARIN PHARMACEUTICAL INC 0.44%
SUMMIT THERAPEUTICS INC 0.44%
NEUROCRINE BIOSCIENCES INC 0.44%
BRIDGEBIO PHARMA INC 0.44%
EXELIXIS INC 0.44%
ACADIA PHARMACEUTICALS INC 0.42%
IMMUNOVANT INC 0.42%
NUVALENT INC-A 0.42%
ALNYLAM PHARMACEUTICALS INC 0.42%
UNITED THERAPEUTICS CORP 0.42%
INTELLIA THERAPEUTICS INC 0.4%
BIOCRYST PHARMACEUTICALS INC 0.4%
CATALYST PHARMACEUTICALS INC 0.4%
GRAIL INC 0.4%
TANGO THERAPEUTICS INC 0.38%
VERACYTE INC 0.38%
DENALI THERAPEUTICS INC 0.37%
DYNE THERAPEUTICS INC 0.37%
IDEAYA BIOSCIENCES INC 0.36%
ARCUS BIOSCIENCES INC 0.34%
ARCUTIS BIOTHERAPEUTICS INC 0.33%
RECURSION PHARMACEUTICALS-A 0.33%
AGIOS PHARMACEUTICALS INC 0.32%
MINERALYS THERAPEUTICS INC 0.32%
SYNDAX PHARMACEUTICALS INC 0.32%
SAREPTA THERAPEUTICS INC 0.32%
DISC MEDICINE INC 0.3%
CELLDEX THERAPEUTICS INC 0.3%
VIRIDIAN THERAPEUTICS INC 0.3%
ADMA BIOLOGICS INC 0.29%
NOVAVAX INC 0.28%
IOVANCE BIOTHERAPEUTICS INC 0.26%
PALVELLA THERAPEUTICS INC 0.26%
BIOHAVEN LTD 0.25%
IMMUNOME INC 0.25%
CAPRICOR THERAPEUTICS INC 0.24%
NURIX THERAPEUTICS INC 0.24%
ABSCI CORP 0.24%
HYPERLIQUID STRATEGIES 0.23%
VERICEL CORP 0.23%
KODIAK SCIENCES INC 0.23%
STOKE THERAPEUTICS INC 0.21%
ANAPTYSBIO INC 0.21%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.